Gilbert Marciniak
13Patents
3h-index
30Co-inventors
60Inventor score
Filing activity: Jan 10, 1992 → Feb 21, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5698696A | Process for preparing 2,3-dihydro-benzofuranol derivatives | Emerging Cross-Sectional Technologies | 14 | Expired |
| US8846670B2 | 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US5270336A | Ascorbic acid derivatives | Chemistry; Metallurgy | 4 | Expired |
| US8242126B2 | Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof | Chemistry; Metallurgy | 2 | Active |
| US9321790B2 | Pyrimidinone derivatives as antimalarial agents | Emerging Cross-Sectional Technologies | 2 | Active |
| US8846654B2 | Therapeutic applications in the cardiovascular field of quinazolinedione derivatives | Human Necessities | 1 | Active |
| US8722659B2 | Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10253043B2 | 2,3-dihydro-1H-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof | Chemistry; Metallurgy | 0 | Active |
| US9120812B2 | Pyrimidooxazocine derivatives as mTOR-inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11739100B2 | 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof | Chemistry; Metallurgy | 0 | Active |
| US8828997B2 | 2,3-dihydro-1H-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US5175188A | Ascorbic acid derivatives | Human Necessities | 0 | Expired |
| US8748441B2 | Therapeutic uses of quinazolinedione derivatives | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.